Novartis International AGFounded
1996 (from merger)
Headquarters
Basel, Switzerland
General information
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland that manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate hydrochloride (Ritalin), terbinafine (Lamisil), and others. Novartis owns Sandoz, a large manufacturer of generic drugs. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on 1 September 2007.[2] [3]Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations
HistoryNovartis was created in 1996 from the merger of Ciba-Geigy and Sandoz Laboratories, both Swiss companies with long histories. At the time it was said[weasel words] to be the largest corporate merger in history. Ciba-Geigy was formed in 1970 by the merger of J. R. Geigy Ltd (founded in Basel in 1758) and Ciba (founded in Basel in 1859). Combining the histories of the merger partners, the company's effective history spans 250 years
Diovan, Exelon, Lamisil, Gleevec, Lotrel, Zometa, Neoral, Femara Zelnorm, Benefiber, Clomicalm, Voltaren, Tegretol, Reclast etc.
▲US$ 38 billion
98,200
No comments:
Post a Comment